Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
QNRX
$6.79
-1.59%
QNRX
· Quoin Pharmaceuticals Ltd.
$6.79
-0.11 (-1.59%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based upon the Company's current business plans and cash, cash equivalents, and investments on hand, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least one year from the date of the filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.64M
Shares
2.01M
All earnings calls
Earnings call · FY2025 Q4
Quoin Pharmaceuticals Ltd. (QNRX) Q4 2025 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 26, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 26, 2026 · complete as-filed document